The enterochromaffin-like (ECL) cells, which are the predominant endocrine cell type in the acid-producing part of the vertebrate stomach, are characterized by numerous, electron-lucent vesicles and few electron-dense granules in the cytoplasm. The biological and physiological significance of the ECL cells remains poorly understood. They produce and store histamine and pancreastatin and are thought to produce an as yet unidentified peptide hormone. The most important clue to their function is their willingness to respond to changes in circulating gastrin. The present review presents current knowledge of the biology and physiology of the rat stomach ECL cells.
INTRODUCTION
The so-called enterochromaffin-like (ECL)d cells have attracted much attention in recent years. Nonetheless, their physiological significance remains poorly understood. They are histamine-producing and peptide-hormone-producing cells that occur exclusively in the acid-producing gastric mucosa [1] [2] [3] [4] [5] . Several different endocrine cell types can be demonstrated in this location [6] [7] [8] [9] . Together they represent about two percent of the cells in the acid-producing mucosa of the rat; the corresponding figure in man is 0.5 to one percent. This means that the endocrine cells in the acid-producing mucosa constitute an endocrine organ that is about equal in size to the endocrine pancreas. In the rat, the ECL cells comprise at least 65 percent of the endocrine cells [5, 7] , the corresponding figure in man is 30-35 percent [7] . The ECL cells can be demonstrated-albeit not selectively-by silver-staining techniques and also by immunocytochemistry, taking advantage of the fact that they contain histamine and the histamine-forming enzyme, histidine decarboxylase (HDC). In mammals, they occur predominantly in the basal half, sometimes in the basal third, of the acid-producing mucosa in the chief-cell-rich region.
ULTRASTRUCTURAL FEATURES OF THE ECL CELL
The ECL cells are best defined by their characteristic ultrastructure [1, 2, 6, 8, 9] . They are irregular in shape, often displaying prominent extensions, and they contain electron-dense granules and electron-lucent vesicles ( Figure 1 ). The ultrastructure of the ECL cells distiguishes them from all other endocrine cell types in the gastric mucosa. Besides histamine and the anticipated peptide hormone, the ECL cells produce chromogranin A, which is a member of the chromogranin/secretogranin family and occurs in many peptide hormone-producing cells [10] [11] [12] [13] [14] [15] . Chromogranin A and its cleavage products are costored with biogenic amines and regulatory peptides and are thought to play a role in the formation and stabilization of secretory granules [15] . Chromogranin A is proteolytically processed to yield fragments, one such fragment is pancreastatin, which has been demonstrated in the ECL cells [10] .
The cytoplasmic vesicles in the ECL cells are numerous and of varying size, often quite large; they are empty-looking or contain a small, eccentrically-located dense core [16] [17] [18] . The granules are few and small in size and have a dense core that is separated from the enclosing membrane by a thin electron-lucent halo. Examination of serially sectioned ECL cells has revealed that the vesicles almost invariably contain an electrondense core (Figure 2 ), suggesting that perhaps the distinction between granules and vesicles is artificial. We have argued previously that granules probably develop into vesicles as a result of progressive accumulation of pre-formed histamine from the cytoplasm and that they grow in size during this process, possibly through osmotic forces generated by the resulting high local concentration of histamine [17] [18] (Figure 3) .
If the histamine-containing ECL cells are exposed to exogenous 5-hydroxytryptophan or DOPA, they are able to take up and decarboxylate these amino acids and to store the resulting amine, 5-hydroxytryptamine (5-HT) or dopamine, in the cytoplasm [19] . Histochemistry at the electron microscopic level suggested that the newly formed amine was in fact confined to the dense core of the granules and vesicles [1, 20] . Rubin and Schwartz [21] used autoradiographic technique to show labelling of secretory organelles in the ECL cells with 3H-5-HT after incubating tissue specimens with 3H-5-hydroxytryptophan. In a subsequent study, Rubin and Schwartz [22] labelled ECL cells with 3H-histidine. However, the labelling in the cytoplasm, which reflected the presence of 3H-histamine, could not be convincingly associated with the vesicles. Using immunocytochemistry at the electron microscopic level, Delwaide et al. [23] recently demonstrated histamine in ECL cell granules, while Nissinen and Panula [5] failed to do so. The failure to demonstrate histamine label or histamine immunostaining over granules and vesicles may reflect diffusion of histamine from its subcellular storage site because of inadequate fixation and processing of the specimens. Although direct evidence for the storage of histamine in the secretory organelles is still missing, available information seems to favour the view that amine storage in the ECL cell is associated with granules and vesicles ( Figure 3 IMMEDIATE RESPONSE OF THE ECL CELL TO GASTRIN The ECL cells respond to gastrin according to a preset time table. An acute challenge with maximal doses of gastrin in the form of a sustained intravenous infusion to conscious rats results in a prompt reduction of the number of vesicles per cell profile, lowering of the concentration of histamine in the oxyntic mucosa (reflecting the release of histamine [24] ) ( Figure 4 ) and release of pancreastatin [25] (Figure 5 ). Gastrin-evoked histamine release has been observed also in isolated ECL cells [26] . Half an hour after the start of gastrin infusion, approximately 50 The association between gastrin-stimulated degranulation on one hand and secretion of histamine and pancreastatin on the other supports the view that the two secretory products are stored together in granules and/or vesicles. However, the reduction in mucosal histamine did not completely parallel that of pancreastatin, in that the drop in histamine occurred much sooner after start of gastrin infusion than did the drop in pancreastatin, and in that mucosal histamine was replenished much faster than was pancreastatin [26] . Also, the release of pancreastatin into the circulation seemed to occur more slowly than what has been described for histamine [24, 27] . These discrepancies may favour the view that histamine and pancreastatin do not occur together in the same secretory organelles, or that the two secretory products are co-stored but not necessarily in the same compartment and/or not in fixed proportions. Secretory products in the resting ECL cell may occur in two pools, one close to the cell membrane and immediately available for release ("mature" vesicles) and another restrained from contact with release sites in the cell membrane, either by sheer distance or by the organization of the cytoskeleton (granules and "immature" vesicles) (Figure 3) . Conceivably, the readily releasable pool contains proportionately more histamine than pancreastatin while the opposite is the case for the reserve pool. It can be assumed that chromogranin A is deposited in the secretory organelle at the time of its formation in the Golgi apparatus, whereas histamine is being taken up preformed from the cytoplasm at a much later stage. Hence, it is to be expected that the proportion of histamine versus chromogranin A-derived peptides (for instance pancreastatin) may vary depending upon the age of the organelle.
Histamine is rapidly replenished as a result of the increased HDC activity. It has been suggested that the release of histamine and the activation of HDC are coupled so that the release of histamine triggers the activation of HDC and that the HDC activity is turned off when the histamine stores have been replenished [28] . The present results show the HDC activity to increase quite slowly at first; after 30-60 min of infusing gastrin the enzyme activity started to increase more rapidly until reaching a plateau at six hr ( Figure  6A ). It should be noted that although the increase in HDC activity was initiated when the histamine concentration in the oxyntic mucosa was lowered, it continued long after histamine replenishment, suggesting that the activation of HDC is independent of the concentration of histamine, or perhaps more likely, that the activation of HDC is initiated by the lowering of histamine (or by the combination of gastrin stimulation and lowering of histamine) and maintained by gastrin stimulation.
The activation of HDC appears to be associated with a progressive increase in the level of HDC mRNA ( Figure 6B) . Interestingly, the gastrin-evoked increase in HDC mRNA was slower and less marked than the increase in HDC activity [25] . The activation of HDC is generally thought to reflect de novo synthesis of enzyme [29] . In [16, 18] . The cells remain enlarged for at least 28 days, the longest time studied. The cytoplasmic vesicles display an altered appearance following a period of sustained hypergastrinemia. Many of them become very large, giving the impression that they result from fusion of several smaller vesicles [16] (Figure 3) .
In the time course of events that takes place in the ECL cells in response to sustained hypergastrinemia (whether of endogenous or exogenous origin) the next step is stimulated self replication [30] . The ECL cells are capable of dividing, and although their mitotic activity is low, it appears to be sufficient to maintain the ECL cell population. Sustained elevation of the circulating gastrin levels, induced by gastrin infusion, by pharmacological treatment with inhibitors of acid secretion (omeprazole, ranitidine) or by surgery, e.g., partial removal of the acid-producing part of the stomach (partial fundectomy) or antrum exclusion, stimulates mitosis in the ECL cells and induces hyperplasia [31] [32] [33] [34] [35] [36] [37] [38] [39] . The labelling index (LI), i.e., the proportion of ECL cells that incorporate 3H-thymidine in preparation for mitosis, is elevated almost 10-fold after about 10 days of omeprazoleevoked hypergastrinemia, but this effect is transient; after 10 and 20 weeks, the LI is back to pre-stimulation values in spite of the maintained hypergastrinemia [30] (Figure 7A ). The actual increase in the number of ECL cells in the oxyntic mucosa progressed quite slowly by comparison and reached a maximum of about four-fold increase after 20 weeks and up to 52 weeks of hypergastrinemia [30] ( Figure 7B) . Interestingly, the HDC activity, which is thought to reflect the functional activity of the ECL cells, still remained elevated after 20 weeks ( Figure 7C ). The decline in ECL cell LI during long-term omeprazoleevoked hypergastrinemia might reflect an impaired ability to respond to gastrin because of receptor down-regulation or because of local accumulation of growth inhibitors [40] . The fact that the ability of gastrin to activate HDC was not impaired indicates that gastrin retains its ability to activate the ECL cells (reflected in HDC activities well above control levels) at a stage when it had a reduced effect as a growth-stimulating factor (reflected in a LI at control level). This could be interpreted to mean either that the gastrin receptor responsible for the trophic response is distinct from the receptor responsible for activating the cells or that the gastrin-induced responses in the ECL cells are mediated via two independent post-receptor pathways, one of which is off-set by a long-lasting gastrin challenge while the other is not.
PHYSIOLOGICAL SIGNIFICANCE OF THE ECL CELLS It has turned out to be difficult to define what physiological role the ECL cells fulfill. The most important clue to the function of the ECL cells is their willingness to respond to changes in circulating gastrin. This feature has made the ECL cells the prime suspect for a role as local supplier of histamine to stimulate the parietal cells. The significance of ECL cell histamine can be studied by the use of a-fluoromethylhistidine (a-FMH) an irreversible inhibitor, a so-called suicide inhibitor, of HDC. Treatment of rats with a-FMH results in irreversible inhibition of HDC and reduces the histamine concentration in the oxyntic mucosa by about 80 percent [17, 41] . It could be shown by immunocytochemistry that a-FMH depletes histamine from the ECL cells but not from the mast cells, which are few in the oxyntic mucosa of the rat. Interestingly, histamine depletion was associated with a marked loss of cytoplasmic vesicles, and the few that remained were quite small [17, 41] . This observation supports the contention that granules develop into vesicles as a result of intragranular accumulation of histamine. Hence, it might be speculated that granules are "young and immature" and that vesicles are more "mature" (Figure 3 ). ECL cell histamine depletion has important functional consequences. Basal and gastrin-stimulated acid secretion is suppressed while histamine-and vagally-stimulated acid secretion is unaffected [42] . Histamine-depleted ECL cells were found to respond to the growth-stimulating effects of gastrin much like normal ECL cells. Also, the gastrin-evoked growth of the oxyntic mucosa was unaffected by depletion of ECL cell histamine [41] .
In a discussion of the biology of the ECL cells, it may be pertinent to point out that the ECL cell hormone still remains to be identified. Hormone deprivation (i.e., gastrectomy) should be one way to identify the type of hormone produced by the ECL cells. Gastrectomy has a number of quite dramatic consequences, some of which concern impairment in bone architecture and a deficient calcium homeostasis. Thus, gastrectomy ). Mean ± SEM (vertical bars, n = 4-9 rats). The mRNAs for HDC and Bactin were analyzed by Northern blot using 32p-labelled cRNA probes; the levels were determined (semi-quantitatively) by densitometric scanning after autoradiography [25] . caused rapid bone loss and a marked reduction in trabecular bone volume [43] [44] [45] . These effects do not reflect the loss of gastric acid since omeprazole-induced blockade of gastric acid secretion did not reproduce the efffects of gastrectomy. The gastrectomy-evoked osteoporosis could be prevented only partly or not at all by supplementation with calcium [44] , and it cannot be excluded that the bone loss reflects a gastric hormone deficiency rather than calcium deficiency. Moreover, gastrectomized rats respond to an oral CaCl2 load with a marked hypercalcemia, unlike intact rats that do not display any perturbation of blood Ca2+ levels under identical circumstances (Hakanson, in preparation) . Conceivably, the acid-producing part of the stomach harbours an anti-hypercalcemic signal that can be released by gastrin. In addition, gastrectomy greatly aggravates the hypocalcemia that ensues following parathyroidectomy [46] . The Gastrin is said to have two physiologically important actions: stimulating acid secretion and stimulating growth of the oxyntic mucosa, notably the ECL cells. The acid-stimulating effect of gastrin seems to be largely mediated by the gastrin-induced release of histamine from the ECL cells. In view of the powerful stimulating effect of gastrin on the ECL cells, it is tempting to suggest that the primary effect of gastrin is to stimulate the ECL cells and to cause secretion of histamine and the ECL cell hormone.
